Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: A multicenter randomized controlled study

European Journal of Haematology

Volumn 58, Issue 4, 1997, Pages 265-272

  Bessho, Masami ^a   Hirashima, Kunitake ^a   Asano, Shigetaka ^b   Ikeda, Yasuo ^c   Ogawa, Nobuya ^d   Tomonaga, Masao ^e   Toyama, Keisuke ^f   Nakahata, Tatsutoshi ^b   Nomura, Takeo ^g   Mizoguchi, Hideaki ^h   Yoshida, Yataro ⁱ   Niitsu, Yoshiro ^j   Kohgo, Yutaka ^k  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d EHIME UNIVERSITY   (Japan)

^e NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

ⁱ KYOTO UNIVERSITY   (Japan)

^j SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k ASAHIKAWA MEDICAL COLLEGE   (Japan)

more..

Author keywords

aplastic anemia (AA); CSF; EPO; G

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 8244252290     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb01665.x     Document Type: Article

References (24)

1. GALE RP, CHAMPLIN RE, FEIG SA, FRITCHEN JH. Aplastic anemia: biology and treatment. Ann Intern Med 1981: 95: 477-494.
2. CAMITTA BM, STORB R, THOMAS ED. Aplastic anemia: pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 1982: 306: 645-652.
3. YOUNG NS, BARRETT AJ. The treatment of severe acquired aplastic anemia. Blood 1995: 85: 3367-3377.
4. STORB R, THOMAS ED, BUCKNER CD, et al. Marrow transplantation for aplastic anemia. Semin Hematol 1984: 21: 27-35.
5. ROSENFELD SJ, KIMBALL J, VINING D, YOUNG NS. Intensive immuno suppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995: 11: 3058-3065.
6. BACIGALUPO A, BROCCIA G, CORDA G, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA working party. Blood 1995: 85: 1348-1353.
7. MARSH JCW, GORDON-SMITH ED. Treatment of aplastic anaemia with antilymphocyte globulin and cyclosporin. Int J Hematol 1995: 62: 133-144.
8. ASANO S, HIRASHIMA K, YOSHIDA Y, et al. Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia. Jpn J Clin Hematol 1990: 31: 1456-1462.
9. BESSHO M, JINNAI I, MATSUDA A, SAITO M, HIRASHIMA K. Improvement of anemia by recombinant human erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Int J Cell Cloning 1990: 8: 445-458.
10. URABE A, MIZOGUCHI H, TAKAKU F, et al. Effects of rHuEPO on aplastic anemia: results of a phase II clinical study. Jpn J Clinical Hematol 1993: 34: 1002-1010.
11. BESSHO M, TOYODA A, ITOH Y, et al. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia. Br J Haematol 1992: 80: 409-411.
12. BESSHO M, JINNAI I, HIRASHIMA K, et al. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia. Stem Cells 1994: 12: 604-615.
13. IMAMURA M, KOBAYASHI M, KOBAYASHI S, et al. Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia. Am J Hematol 1995: 48: 29-33.
14. SONODA Y, OHNO Y, FUJII H, et al. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony-stimulating factor). Stem Cells 1993: 11: 543-554.
15. BESSHO M, JINNAI I, MATSUDA A, et al. Trilineage recovery by long-term combination therapy with recombinant human granulocyte colony-stimulating factor and erythroietin in patients with aplastic anemia and refractory anemia. In: NOMURA T, YOSHIDA Y, eds. Myelodysplastic syndromes: advances in research and treatment. Amsterdam: Elsevier, 1995: 325.
16. MATSUBARA K, YOSHIMURA T, KAMACHI S, FUKUSHIMA M, HINO M, MORII H. Sensitive radioimmunoassay for the detection of erythropoietin antibody with high affinity constant. Clin Chim Acta 1989: 185: 177-184.
17. KOHGO Y, NISHISATO T, KONDO H, TSUSHIMA N, NIITSU Y, URUSHIZAKI I. Circulating transferrin receptor in human serum. Br J Haematol 1986: 64: 277-281.
18. NEGRIN RS, STEIN R, VARDIMAN J, et al. Treatment of the anemia of myelodysplastic sydromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood 1993: 82: 737-743.
19. HELLSTROM-LINDBERG E, BIRGEGARD G, CARLSSON M, et al. A combination of granulocyte colony-stimulating factor and erythropoietin may synergistically improve the anaemia in patients with myelodysplastic syndromes. Leuk Lymph 1993: 11: 221-228.
20. KOHGO Y, NIITSU Y, KONDO H, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood 1987: 70: 1955-1958.
21. BEGUIN Y, LOO M, ZIK S, et al. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood 1993: 82: 2010-2016.
22. LUDWIG H, FRITZ E, LEITGEB C, PECHERSTORFER M, SAMONIGG H, SCHUSTER J. Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood 1994: 84: 1056-1063.
23. SOCIE G, HENRY-AMAR M, BACIGALUPO A, et al. Malignant tumors occuring after treatment of aplastic anemia. N Engl J Med 1993: 329: 1152-1157.
24. ERSLEV AJ. Erythropoietin. N Engl J Med 1991: 324: 1339-1344.